Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants — Stella

Home/Type 2 Diabetes Mellitus in Obese/

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes Mellitus in Obese trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Texas Diabetes Institute/UH, San Antonio, Texas

Key details

Phase

Post-approval study

Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment target

~78 participants

Started

July 2023

Primary completion

August 2029

Age range

30 Years – 70 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.